Document:

2010 Equity Compensation Plan of the Registrant

 Exhibit 10.1 
 USMD HOLDINGS, INC. 
 2010 EQUITY COMPENSATION PLAN 

The purpose of the USMD Holdings, Inc. 2010 Equity Compensation Plan (the “Plan”) is to provide
(i) designated employees of USMD Holdings, Inc. (the “Company”) and its subsidiaries, (ii) certain consultants and advisors who perform services for the Company or its subsidiaries and (iii) non-employee members of the Board
of Directors of the Company (the “Board”) with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights and restricted stock. The Company believes that the Plan will encourage the
participants to contribute materially to the growth of the Company, thereby benefiting the Company’s shareholders, and will align the economic interests of the participants with those of the shareholders. The Plan shall become effective upon
the consummation of the “Contribution” referenced in Section 2(b) hereinbelow. 
 1. Administration 

 (a) Compensation Committee. The Plan shall be administered and interpreted by the Compensation
Committee of the Board. The Committee shall consist of two or more persons appointed by the Board, all of whom shall be “outside directors” as defined under section 162(m) of the Internal Revenue Code of 1986, as amended (the
“Code”) and related Treasury regulations and may be “non-employee directors” as defined under Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). If at any time the Board has not
established the Committee, the Plan shall be administered and interpreted by the Board acting as a whole, and references in the Plan to the “Committee” shall be deemed to mean the entire Board. 

(b) Committee Authority. The Committee shall have the sole authority to (i) determine the individuals to whom
grants shall be made under the Plan, (ii) determine the type, size and terms of the grants to be made to each such individual and (iii) determine the time when the grants will be made and the duration of any applicable exercise or
restriction period, including the criteria for exercisability and the acceleration of exercisability. The Committee shall also have full power and authority to administer and interpret the Plan, to make factual determinations and to adopt or amend
such rules, regulations, agreements and instruments for implementing the Plan and for the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee’s interpretations of the Plan and all determinations
made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform as to similarly situated individuals. 

 2. Grants. 

(a) General. Awards under the Plan may consist of grants of incentive stock options as described in Section 5
(“Incentive Stock Options”), nonqualified stock options as described in Section 5 (“Nonqualified Stock Options”) (Incentive Stock Options and Nonqualified Stock Options are collectively referred to as “Options”),
restricted stock as described in Section 6 (“Restricted Stock”) and stock appreciation rights as described in Section 7 (“SARs”) (hereinafter collectively referred to as “Grants”). All Grants shall be subject
to the terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate and as are specified in writing by the Committee to the individual in a grant instrument (the
“Grant Instrument”) or an amendment to the Grant Instrument. The Committee shall approve the form and provisions of each Grant Instrument. Grants under a particular Section of the Plan need not be uniform as among the grantees. 

(b) Assumption of Outstanding USMD Inc. Stock Options. In connection with the contribution by the holders of USMD
Inc. common stock of their shares in exchange for shares of Company Stock (the “Contribution”), the Company and USMD Inc. have agreed that all outstanding stock options granted under the USMD Inc. 2007 Long Term Incentive Plan (the
“2007 Plan”) will be assumed under this Plan (an “Assumed Option”) and deemed to constitute stock options granted under this Plan. The number of shares of Company Stock subject to an Assumed Option will equal the number of shares
of USMD Inc. common stock subject to the Assumed Option immediately prior to completion of the Contribution, multiplied by [insert exchange ratio] rounded down to the nearest whole share. The per share exercise price for the Assumed Option
will equal the exercise price of the Assumed Option immediately prior to completion of the Contribution divided by [insert exchange ratio], rounded up to the nearest whole cent. Assumed Options will be exercisable on the same terms and
conditions that applied immediately prior to completion of the Contribution. 
 3. Shares Subject to the Plan
 
 (a) Shares Authorized. Subject to the adjustment specified below, the aggregate number of shares
of common stock of the Company (“Company Stock”) that may be issued or transferred under the Plan is 1,000,000 shares, the maximum number of shares of Company Stock that may be delivered pursuant to Incentive Stock Options is 900,000
shares; and the maximum number of shares of Company Stock which may be represented by Grants of Restricted Stock and SARs shall not exceed 100,000 shares. The maximum aggregate number of shares of Company Stock that shall be subject to Grants made
under the Plan to any individual during any calendar year shall be 500,000 shares. The shares may be authorized but unissued shares of Company Stock or reacquired shares of Company Stock, including shares purchased by the Company on the open market
for purposes of the Plan. If and to the extent Options granted under the Plan terminate, expire, or are canceled, forfeited, exchanged or surrendered without having been exercised or if any shares of Restricted Stock are forfeited, the shares
subject to such Grants shall again be available for purposes of the Plan. 

  
 2 

 (b) Adjustments. If there is any change in the number or kind of
shares of Company Stock outstanding (i) by reason of a stock dividend, spinoff, recapitalization, stock split, or combination or exchange of shares, (ii) by reason of a merger, reorganization or consolidation in which the Company is the
surviving corporation, (iii) by reason of a reclassification or change in par value, or (iv) by reason of any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company’s receipt of
consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or the Company’s payment of an extraordinary dividend or distribution, the maximum number of shares of Company Stock
available for Grants, the maximum number of shares of Company Stock that any individual participating in the Plan may be granted in any year, the number of shares covered by outstanding Grants, the kind of shares issued under the Plan, and the price
per share or the applicable market value of such Grants shall be appropriately adjusted by the Committee to reflect any increase or decrease in the number of, or change in the kind or value of, issued shares of Company Stock to preclude, to the
extent practicable, the enlargement or dilution of rights and benefits under such Grants; provided, however, that any fractional shares resulting from such adjustment shall be eliminated. Any adjustments determined by the Committee shall be final,
binding and conclusive. 
 4. Eligibility for Participation  

(a) Eligible Persons. All employees of the Company and its subsidiaries (“Employees”), including
Employees who are officers or members of the Board, and members of the Board who are not Employees (“Non-Employee Directors”), shall be eligible to participate in the Plan. Consultants and advisors who perform services to the Company or
any of its subsidiaries (“Key Advisors”) shall be eligible to participate in the Plan if the Key Advisors render bona fide services and such services are not in connection with the offer or sale of securities in a capital-raising
transaction. 
 (b) Selection of Grantees. The Committee shall select the Employees, Non-Employee
Directors and Key Advisors to receive Grants and shall determine the number of shares of Company Stock subject to a particular Grant in such manner as the Committee determines. Employees, Key Advisors and Non-Employee Directors who receive Grants
under this Plan shall hereinafter be referred to as “Grantees.” 
 5. Granting of Options 

 (a) Number of Shares. The Committee shall determine the number of shares of Company Stock that will be
subject to each Grant of Options to Employees, Non-Employee Directors and Key Advisors. 

  
 3 

 (b) Type of Option and Price. 

(i) The Committee may grant Incentive Stock Options that are intended to qualify as “incentive stock options”
within the meaning of section 422 of the Code or Nonqualified Stock Options that are not intended so to qualify or any combination of Incentive Stock Options and Nonqualified Stock Options, all in accordance with the terms and conditions set forth
herein. Incentive Stock Options may be granted only to Employees. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and Key Advisors. 

(ii) The purchase price (the “Exercise Price”) of Company Stock subject to an Option shall be determined by the
Committee but in all cases shall be equal to, or greater than, the Fair Market Value of a share of Company Stock on the date the Option is granted; provided, however, that an Incentive Stock Option may not be granted to an Employee who, at the time
of grant, owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary of the
Company, unless the Exercise Price per share is not less than 110% of the Fair Market Value of Company Stock on the date of grant. 
 (iii) So long as the Company Stock is publicly traded, Fair Market Value per share shall be determined as follows: (x) if the principal trading market for the Company Stock is a national securities
exchange or the Nasdaq Stock Market, the last reported sale price thereof on the relevant date or (if there were no trades on that date) the latest preceding date upon which a sale was reported, or (y) if the Company Stock is not principally
traded on such exchange or market, the mean between the last reported “bid” and “asked” prices of Company Stock on the relevant date, as reported on Nasdaq or, if not so reported, as reported in a customary financial reporting
service, as applicable and as the Committee determines. If the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions or “bid” or “asked” quotations as set forth above, the Fair
Market Value per share shall be as determined by the Committee. 
 (iii) If at any time the Company Stock is not
publicly traded, Fair Market Value per share shall be as determined by the Committee. 
 (c) Option Term.
The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant. However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more
than 10 percent of the total combined voting power of all classes of stock of the Company, or any parent or subsidiary of the Company, may not have a term that exceeds five years from the date of grant. 

(d) Exercisability of Options. Options shall become exercisable in accordance with such terms and conditions,
consistent with the Plan, as may be determined by the Committee and specified in the Grant Instrument or an amendment to the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options at any time for any
reason. 

  
 4 

 (e) Termination of Employment, Disability or Death. 

(i) Except as provided below, an Option may only be exercised while the Grantee is employed by the Company
as an Employee, Key Advisor or member of the Board. In the event that a Grantee ceases to be employed by the Company for any reason other than a “disability” or death, any Option which is otherwise exercisable by the Grantee shall
terminate unless exercised within 90 days after the date on which the Grantee ceases to be employed by the Company (or within such other period of time as may be specified by the Committee), but in any event no later than the date of expiration
of the Option term. Any of the Grantee’s Options that are not otherwise exercisable as of the date on which the Grantee ceases to be employed by the Company shall terminate as of such date. Notwithstanding the foregoing provisions of this
Section, in the event a Grant issued under the Plan is subject to Section 409A of the Code, then, to the extent necessary to comply with the requirements of Section 409A of the Code, a Grantee shall be considered to cease employment with
the Company for any reason other than a disability or death, provided that such employment shall cease in accordance with the definition of “separation from service” provided for under Section 409A of the Code and the regulations or
other guidance issued thereunder. 
 (ii) In the event the Grantee ceases to be employed by the
Company because the Grantee is “disabled”, any Option which is otherwise exercisable by the Grantee shall terminate unless exercised within one year after the date on which the Grantee ceases to be employed by the Company (or within such
other period of time as may be specified by the Committee), but in any event no later than the date of expiration of the Option term. Any of the Grantee’s Options which are not otherwise exercisable as of the date on which the Grantee ceases to
be employed by the Company shall terminate as of such date. 
 (iii) If the Grantee dies while
employed by the Company or within 90 days after the date on which the Grantee ceases to be employed on account of a termination of employment specified in Section 5(e)(i) above (or within such other period of time as may be specified by
the Committee), any Option that is otherwise exercisable by the Grantee shall terminate unless exercised within one year after the date on which the Grantee ceases to be employed by the Company (or within such other period of time as may be
specified by the Committee), but in any event no later than the date of expiration of the Option term. Any of the Grantee’s Options that are not otherwise exercisable as of the date on which the Grantee ceases to be employed by the Company
shall terminate as of such date. 
 (iv) As used herein: 

(A) “Employed by the Company” shall mean employment or service as an Employee, Key Advisor or
member of the Board (so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Restricted 

  
 5 

 
Stock, a Grantee shall not be considered to have terminated employment or service until the Grantee ceases to be an Employee, Key Advisor and member of the Board), unless the Committee determines
otherwise. 
 (B) “Disability” shall mean a Grantee’s becoming disabled within the
meaning of section 22(e)(3) of the Code. Notwithstanding the foregoing provisions of this Section 5(e)(iv)(C), in the event a Grant issued under the Plan is subject to Section 409A of the Code, then, in lieu of the foregoing definition and
to the extent necessary to comply with the requirements of Section 409A of the Code, the definition of “disability” for purposes of such Grant shall be the definition of “disability” provided for under Section 409A of
the Code and the regulations or other guidance issued thereunder. 
 (v) Notwithstanding anything
to the contrary in this Plan, (i) if upon the date of a Grantee’s termination of employment with the Company, the Grantee is a “specified employee” within the meaning of Section 409A of the Code, and the delay of any amounts
otherwise payable under this Plan as a result of the Grantee’s termination of employment is necessary in order to prevent any accelerated or additional tax to Grantee under Section 409A of the Code, then the Company will delay the payment
of any such amounts hereunder until the date that is six (6) months following the date of Grantee’s termination of employment with the Company at which time any such delayed amounts will be paid to Grantee in a single lump sum. 

(f) Exercise of Options. A Grantee may exercise an Option that has become exercisable, in whole or in part, by
delivering a notice of exercise to the Company with payment of the Exercise Price. The Grantee shall pay the Exercise Price for an Option in cash or by such other method as the Committee may approve, including payment through a broker in accordance
with procedures permitted by Regulation T of the Federal Reserve Board. The Grantee shall pay the Exercise Price and the amount of any withholding tax due at the time of exercise. 

(g) Limits on Incentive Stock Options. Each Incentive Stock Option shall provide that, if the aggregate Fair
Market Value of the stock on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Grantee during any calendar year, under the Plan or any other stock option plan of the Company or a parent or
subsidiary, exceeds $100,000, then the option, as to the excess, shall be treated as a Nonqualified Stock Option. An Incentive Stock Option shall not be granted to any person who is not an Employee of the Company or a parent or subsidiary (within
the meaning of section 424(f) of the Code). 

  
 6 

 6. Restricted Stock Grants. The Committee may issue or transfer
shares of Company Stock to an Employee, Non-Employee Director or Key Advisor under a Grant of Restricted Stock, upon such terms as the Committee deems appropriate. The following provisions are applicable to Restricted Stock: 

(a) General Requirements. Shares of Company Stock issued or transferred pursuant to Restricted Stock Grants may be
issued or transferred for consideration or for no consideration, as determined by the Committee. The Committee may establish conditions under which restrictions on shares of Restricted Stock shall lapse over a period of time or according to such
other criteria as the Committee deems appropriate. The period of time during which the Restricted Stock will remain subject to restrictions will be designated in the Grant Instrument as the “Restriction Period.” 

(b) Number of Shares. The Committee shall determine the number of shares of Company Stock to be issued or
transferred pursuant to a Restricted Stock Grant and the restrictions applicable to such shares. 
 (c)
Requirement of Employment. If the Grantee ceases to be employed by the Company during a period designated in the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Restricted Stock Grant shall
terminate as to all shares covered by the Grant as to which the restrictions have not lapsed, and those shares of Company Stock must be immediately returned to the Company. The Committee may, however, provide for complete or partial exceptions to
this requirement as it deems appropriate. 
 (d) Restrictions on Transfer and Legend on Stock
Certificate. During the Restriction Period, a Grantee may not sell, assign, transfer, pledge or otherwise dispose of the shares of Restricted Stock except to a Successor Grantee as described herein. Each certificate for a share of Restricted
Stock shall contain a legend giving appropriate notice of the restrictions in the Grant. The Grantee shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when all restrictions on such
shares have lapsed. The Committee may determine that the Company will not issue certificates for shares of Restricted Stock until all restrictions on such shares have lapsed, or that the Company will retain possession of certificates for shares of
Restricted Stock until all restrictions on such shares have lapsed. 
 (e) Right to Vote and to Receive
Dividends. Unless the Committee determines otherwise, during the Restriction Period, the Grantee shall not have the right to vote shares of Restricted Stock and to receive any dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee. 
 (f) Lapse of Restrictions. All restrictions imposed
on Restricted Stock shall lapse upon the expiration of the applicable Restriction Period and the satisfaction of all conditions imposed by the Committee. The Committee may determine, as to any or all Restricted Stock Grants, that the restrictions
shall lapse without regard to any Restriction Period. 

  
 7 

 7. Stock Appreciation Rights  

(a) General Requirements. The Committee may grant stock appreciation rights (“SARs”) to an Employee,
Non-Employee Director or Key Advisor. The Committee shall establish the base amount of the SAR at the time the SAR is granted. Unless the Committee determines otherwise, the base amount of each SAR shall be equal to the per share Exercise Price of
the related Option or, if there is no related Option, the Fair Market Value of a share of Company Stock as of the date of Grant of the SAR. 
 (b) Exercisability. A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting and other restrictions as may be specified
in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding SARs at any time for any reason. SARs may only be exercised while the Grantee is employed by the Company or during the applicable period after
termination of employment. 
 (c) Value of SARs. When a Grantee exercises SARs, the Grantee shall receive
in settlement of such SARs an amount equal to the value of the stock appreciation for the number of SARs exercised, payable in cash, Company Stock or a combination thereof. The stock appreciation for an SAR is the amount by which (i) the Fair
Market Value of the underlying Company Stock on the date of exercise of the SAR exceeds (ii) the base amount of the SAR as described in Subsection (a). 
 (d) Form of Payment. The Committee shall determine whether the appreciation in a SAR shall be paid in the form of cash, shares of Company Stock, or a combination of the two, in such proportion as
the Committee deems appropriate. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock shall be valued at their Fair Market Value on the date of exercise of the SAR. If shares of Company Stock are
to be received upon exercise of a SAR, cash shall be delivered in lieu of any fractional share. 
 8.
Withholding of Taxes  
 (a) Required Withholding. All Grants under the Plan shall be subject to
applicable federal (including FICA), state and local tax withholding requirements. The Company shall have the right to deduct from all Grants paid in cash, or from other wages paid to the Grantee, any federal, state or local taxes required by law to
be withheld with respect to such Grants. In the case of Options and other Grants paid in Company Stock, the Company may require the Grantee or other person receiving such shares to pay to the Company the amount of any such taxes that the Company is
required to withhold with respect to such Grants, or the Company may deduct from other wages paid by the Company the amount of any withholding taxes due with respect to such Grants. 

(b) Election to Withhold Shares. If the Committee so permits, a Grantee may elect to satisfy the Company’s
income tax withholding obligation with respect to an Option, SAR or Restricted Stock paid in Company Stock by having shares withheld up to 

  
 8 

 
an amount that does not exceed the Grantee’s applicable marginal tax rate for federal (including FICA), state and local tax liabilities. The election must be in a form and manner prescribed
by the Committee and shall be subject to the prior approval of the Committee. 
 9. Transferability of Grants
 
 (a) Nontransferability of Grants. Except as provided below, only the Grantee may exercise rights
under a Grant during the Grantee’s lifetime. A Grantee may not transfer those rights except by will or by the laws of descent and distribution or, with respect to Grants other than Incentive Stock Options, if permitted in any specific case by
the Committee, pursuant to a domestic relations order (as defined under the Code or Title I of the Employee Retirement Income Security Act of 1974, as amended, or the regulations thereunder). When a Grantee dies, the personal representative or other
person entitled to succeed to the rights of the Grantee (“Successor Grantee”) may exercise such rights. A Successor Grantee must furnish proof satisfactory to the Company of his or her right to receive the Grant under the Grantee’s
will or under the applicable laws of descent and distribution. 
 (b) Transfer of Nonqualified Stock
Options. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument, that a Grantee may transfer Nonqualified Stock Options to family members or other persons or entities according to such terms as the Committee may
determine; provided that the Grantee receives no consideration for the transfer of an Option and the transferred Option shall continue to be subject to the same terms and conditions as were applicable to the Option immediately before the transfer.

 10. Amendment and Termination of the Plan  

(a) Amendment. The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not
amend the Plan without shareholder approval if such approval is required by Sections 421 and 422 of the Code. 
 (b) Termination of Plan. The Plan shall terminate on the day immediately preceding the tenth anniversary of its effective date, unless the Plan is terminated earlier by the Board or is extended by
the Board with the approval of the shareholders. 
 (c) Termination and Amendment of Outstanding Grants.
A termination or amendment of the Plan that occurs after a Grant is made shall not materially impair the rights of a Grantee unless the Grantee consents. The termination of the Plan shall not impair the power and authority of the Committee with
respect to an outstanding Grant. Whether or not the Plan has terminated, an outstanding Grant may be amended by agreement of the Company and the Grantee consistent with the Plan. 

(d) Governing Document. The Plan shall be the controlling document. No other statements, representations,
explanatory materials or examples, oral or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and assigns. 

  
 9 

 11. Funding of the Plan. This Plan shall be unfunded. The Company
shall not be required to establish any special or separate fund or to make any other segregation of assets to assure the payment of any Grants under this Plan. In no event shall interest be paid or accrued on any Grant, including unpaid installments
of Grants. 
 12. Rights of Participants. Nothing in this Plan shall entitle any Employee, Key Advisor,
Non-Employee Director or other person to any claim or right to be granted a Grant under this Plan. Neither this Plan nor any action taken hereunder shall be construed as giving any individual any rights to be retained by or in the employ of the
Company or any other employment rights. 
 13. No Fractional Shares. No fractional shares of Company
Stock shall be issued or delivered pursuant to the Plan or any Grant. The Committee shall determine whether cash, other awards or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any
rights thereto shall be forfeited or otherwise eliminated. 
 14. Miscellaneous 

(a) Grants in Connection with Corporate Transactions and Otherwise. Nothing contained in this Plan shall be
construed to (i) limit the right of the Committee to make Grants under this Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business or assets of any corporation, firm or association,
including Grants to employees thereof who become Employees of the Company, or for other proper corporate purposes, or (ii) limit the right of the Company to grant stock options or make other awards outside of this Plan. Without limiting the
foregoing, the Committee may make a Grant to an employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or liquidation involving the Company or any of
its subsidiaries in substitution for a stock option or restricted stock grant made by such corporation. The terms and conditions of the substitute grants may vary from the terms and conditions required by the Plan and from those of the substituted
stock incentives. The Committee shall prescribe the provisions of the substitute grants. 
 (b) Compliance
with Law. The Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall be subject to all applicable laws and to approvals by any governmental or regulatory agency
as may be required. With respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under
the Exchange Act. The Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules regarding the withholding of taxes on
payments to Grantees. The Committee may, in its sole discretion, agree to limit its authority under this Section. 

  
 10 

 (c) Governing Law. The validity, construction, interpretation and
effect of the Plan and Grant Instruments issued under the Plan shall exclusively be governed by and determined in accordance with the law of State of Texas. 
 15. Section 409A. To the extent this Plan provides for nonqualified deferred compensation, it is intended to satisfy the provisions of Section 409A of the Code and related regulations and
Treasury pronouncements. If any provision herein results in the imposition of an excise tax on any Grantee under Section 409A of the Code, any such provision will be reformed to avoid any such imposition in such manner as the Committee
determines is appropriate to comply with Section 409A of the Code. 

  
 11Second Amendment to Loan and Security Agreement

 Exhibit 10.1 
 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT 
 THIS SECOND
AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Second Amendment” or this “Amendment”) is entered into as of June 20, 2011, by and among HERCULES FUNDING II LLC, a Delaware limited liability company
(“Borrower”), the lenders identified on the signature page hereof (such lenders, together with their respective successors and assigns, are referred to hereinafter each individually as a “Lender” and collectively as
the “Lenders”), and WELLS FARGO CAPITAL FINANCE, LLC, formerly known as Wells Fargo Foothill, LLC, a Delaware limited liability company, as the arranger and administrative agent for the Lenders (“Agent”), with
reference to the following facts, which shall be construed as part of this Second Amendment: 
 RECITALS

 A. Borrower, Lenders and Agent have entered into that certain Loan and Security Agreement dated as of August 25,
2008, as amended by that certain First Amendment to Loan and Security Agreement dated as of April 30, 2009 (as amended or modified from time to time, the “Loan Agreement”), pursuant to which Lenders and Agent are providing
financial accommodations to or for the benefit of Borrower upon the terms and conditions contained therein. Unless otherwise defined herein, capitalized terms or matters of construction defined or established in the Loan Agreement shall be applied
herein as defined or established therein. 
 B. As of the date hereof, Wells Fargo Capital Finance, LLC is the sole Lender under
the Loan Agreement. Pursuant to this Second Amendment, Borrower, Wells Fargo Capital Finance, LLC and Agent are amending the Loan Agreement to, among other things, increase the amount of the Commitment of Wells Fargo Capital Finance, LLC.

 C. Borrower has requested that Lenders and Agent agree to amend certain provisions of the Loan Agreement, and Lenders and
Agent are willing to do so to the extent provided in, and subject to the terms and conditions of, this Second Amendment. 

AGREEMENT 
 NOW, THEREFORE, in consideration of the continued performance by Borrower of its promises and obligations under the Loan Agreement and the other Loan Documents, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, Borrower, Lenders and Agent hereby agree as follows: 
 1. Ratification of Existing Loan Documents. Each of the parties acknowledges, confirms, and ratifies the provisions of the Loan Agreement and the other Loan Documents, which shall be unmodified and
shall continue to be in full force and effect in accordance with their terms except as expressly provided under this Second Amendment. Without limiting the generality of the foregoing, each of the parties acknowledges that the Sale and Servicing
Agreement remains in full force and effect among Borrower, HTGC and Agent notwithstanding the resignation of the Backup Servicer and the fact that a replacement has not and may not be appointed. 

  
 - 1 -

 2. Amendments to the Loan Agreement. The Loan Agreement is hereby amended as follows:

 2.1 Deletion of Definition of ACH Transactions. Section 1.1 of the Loan Agreement is
amended by deleting the existing definition of the term “ACH Transactions.” 
 2.2 Amendment to
Definition of Bank Product. Section 1.1 of the Loan Agreement is amended by deleting the existing definition of the term “Bank Product,” and replacing it with the following amended and restated version thereof: 

“Bank Product” means any one or more of the following financial products or accommodations extended to
Borrower or its Subsidiaries by a Bank Product Provider: (i) credit cards, (ii) credit card processing services, (iii) debit cards, (iv) stored value cards, (v) purchase cards (including so-called “procurement
cards” or “P-cards”), (vi) Cash Management Services, or (vii) transactions under Hedge Agreements. 
 2.3 Addition of Definition of Bank Product Collateralization. Section 1.1 of the Loan Agreement is amended by adding in appropriate alphabetical order the following new definition of
the term “Bank Product Collateralization”: 
 “Bank Product Collateralization” means
providing cash collateral (pursuant to documentation reasonably satisfactory to Agent) to be held by Agent for the benefit of the Bank Product Providers (other than the Hedge Providers) in an amount determined by Agent as sufficient to satisfy the
reasonably estimated credit exposure with respect to the then existing Bank Product Obligations (other than Hedge Obligations). 
 2.4 Amendment to Definition of Bank Product Obligations. Section 1.1 of the Loan Agreement is amended by deleting the existing definition of the term “Bank Product
Obligations” and replacing it with the following amended and restated version thereof: 
 “Bank
Product Obligations” means (a) all obligations, liabilities, reimbursement obligations, fees, or expenses owing by Borrower or its Subsidiaries to any Bank Product Provider pursuant to or evidenced by a Bank Product Agreement and
irrespective of whether for the payment of money, whether direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, (b) all Hedge Obligations, and (c) all amounts that Agent or any Lender is
obligated to pay to a Bank Product Provider as a result of Agent or such Lender purchasing participations from, or executing guarantees or indemnities or reimbursement obligations to, a Bank Product Provider with respect to the Bank Products
provided by such Bank Product Provider to Borrower or its Subsidiaries. 

  
 - 2 -

 2.5 Replacement of Definition of Bank Product Reserve with Definition of
Bank Product Reserve Amount. Section 1.1 of the Loan Agreement is amended by deleting the existing definition of the term “Bank Product Reserve” and replacing it with the following new definition of “Bank Product
Reserve Amount” (and each reference in the Loan Agreement or any other Loan Document to “Bank Product Reserve” shall mean and be a reference to “Bank Product Reserve Amount”): 

“Bank Product Reserve Amount” means, as of any date of determination, the Dollar amount of reserves that
Agent has determined it is necessary or appropriate to establish (based upon the Bank Product Providers’ reasonable determination of their credit exposure to Borrower and its Subsidiaries in respect of Bank Product Obligations) in respect of
Bank Products then provided or outstanding; provided, however, that such amount shall at no time exceed (a) five percent (5%) of the Maximum Revolver Amount at such time, or (b) $15,000,000. 

2.6 Amendment to Definition of Base LIBOR Rate. Section 1.1 of the Loan Agreement is amended by
deleting the existing definition of the term “Base LIBOR Rate” and replacing it with the following amended and restated version thereof: 
 “Base LIBOR Rate” means the per annum rate appearing on Bloomberg L.P.’s (the “Service”) Page BBAM1/(Official BBA USD Dollar Libor Fixings) (or on any successor or
substitute page of such Service, or any successor to or substitute for such Service) two (2) Business Days prior to the commencement of the requested Interest Period, for a term of three (3) months, which determination shall be conclusive
in the absence of manifest error. 
 2.7 Amendment to Definition of Base Rate. Section 1.1 of
the Loan Agreement is amended by deleting the existing definition of the term “Base Rate” and replacing it with the following amended and restated version thereof: 

“Base Rate” means the greatest of (a) the Federal Funds Rate plus one-half of one percent
(0.50%), (b) the LIBOR Rate plus one percent (1.00%), and (c) the rate of interest announced, from time to time, within Wells Fargo at its principal office in San Francisco as its “prime rate”, with the understanding that the
“prime rate” is one of Wells Fargo’s base rates (not necessarily the lowest of such rates) and serves as the basis upon which effective rates of interest are calculated for those loans making reference thereto and is evidenced by the
recording thereof after its announcement in such internal publications as Wells Fargo may designate. 
 2.8
Addition of Definition of Cash Management Services. Section 1.1 of the Loan Agreement is amended by adding the following new definition of the term “Cash Management Services”: 

“Cash Management Services” means any cash management or related services, including treasury, depository,
return items, overdraft, controlled disbursement, merchant store value cards, e-payables services, electronic funds transfer, interstate depository network, automatic clearing house transfer (including the Automated Clearing House processing of
electronic funds transfers through the direct Federal Reserve Fedline system) and other cash management arrangements. 

  
 - 3 -

 2.9 Further Amendment to Definition of Eligible Notes Receivable.
Section 1.1 of the Loan Agreement is further amended by deleting the existing text of clause (e) in the definition of the term “Eligible Notes Receivables” and replacing it with the following amended and restated
version thereof: 
 (e) such Note Receivable has an outstanding principal amount that exceeds $15,000,000;
provided, that only the amount in excess of such limit shall be considered ineligible and such limit may be waived by Agent on a case by case basis in its sole discretion; 

2.10 Amendment to Definition of Fee Letter. Section 1.1 of the Loan Agreement is amended by deleting
the existing definition of the term “Fee Letter” and replacing it with the following amended and restated version thereof: 
 “Fee Letter” means that certain Amended and Restated Fee Letter, dated as of the Second Amendment Closing Date, between Borrower and Agent, in form and substance satisfactory to Agent.

 2.11 Replacement of Definition of Hedging Agreement with Definition of Hedge Agreement.
Section 1.1 of the Loan Agreement is amended by deleting the existing definition of the term “Hedging Agreement” and replacing it with the following new definition of “Hedge Agreement” (and each reference in the Loan
Agreement or any other Loan Document to “Hedging Agreement” shall mean and be a reference to “Hedge Agreement”): 
 “Hedge Agreement” means a “swap agreement” as that term is defined in Section 101(53B)(A) of the Bankruptcy Code. 

2.12 Addition of Definition of Hedge Obligations. Section 1.1 of the Loan Agreement is amended by
adding in appropriate alphabetical order the following new definition of the term “Hedge Obligations”: 

“Hedge Obligations” means any and all obligations or liabilities, whether absolute or contingent, due or
to become due, now existing or hereafter arising, of Borrower or its Subsidiaries arising under, owing pursuant to, or existing in respect of Hedge Agreements entered into with one or more of the Hedge Providers. 

2.13 Addition of Definition of Hedge Provider. Section 1.1 of the Loan Agreement is amended by adding
in appropriate alphabetical order the following new definition of the term “Hedge Provider”: 

“Hedge Provider” means Wells Fargo or any of its Affiliates. 

  
 - 4 -

 2.14 Amendment to Definition of Lender Group Expenses.
Section 1.1 of the Loan Agreement is amended by deleting the existing definition of the term “Lender Group Expenses” and replacing it with the following amended and restated version thereof: 

“Lender Group Expenses” means all reasonable (a) costs or expenses (including taxes, and insurance
premiums) required to be paid by Borrower or its Subsidiaries under any of the Loan Documents that are paid, advanced or incurred by the Lender Group, (b) fees or charges paid or incurred by Agent in connection with the Lender Group’s
transactions with Borrower or its Subsidiaries, including, fees or charges for photocopying, notarization, couriers and messengers, telecommunication, public record searches (including tax lien, litigation, and UCC searches and including searches
with the patent and trademark office, the copyright office, or the department of motor vehicles), filing, recording, publication, appraisal (including initial and subsequent periodic Collateral appraisals or valuations or business valuations to the
extent of the fees and charges therefor (and up to the amount of any limitation contained in this Agreement)), real estate surveys, real estate title policies and endorsements, and environmental audits, (c) Agent’s customary fees and
charges (as adjusted from time to time) with respect to the disbursement of funds (or the receipt of funds) to or for the account of Borrower (whether by wire transfer or otherwise), together with any out-of-pocket costs and expenses incurred in
connection therewith, (by wire transfer or otherwise), (d) charges paid or incurred by Agent resulting from the dishonor of checks, (e) costs and expenses paid or incurred by the Lender Group to correct any default or enforce any provision
of the Loan Documents, or in gaining possession of, maintaining, handling, preserving, storing, shipping, selling, preparing for sale, or advertising to sell the Collateral, or any portion thereof, irrespective of whether a sale is consummated,
(f) out of pocket audit fees and expenses (including travel, meals, and lodging) of Agent related to any inspections or audits to the extent of the fees and charges (and up to the amount of any limitation) contained in the Agreement or the Fee
Letter, (g) costs and expenses of third party claims or any other suit paid or incurred by the Lender Group in enforcing or defending the Loan Documents or in connection with the transactions contemplated by the Loan Documents or the Lender
Group’s relationship with Borrower or any of its Subsidiaries or any Guarantor, (h) Agent’s costs and expenses (including attorneys’ fees) incurred in advising, structuring, drafting, reviewing, administering, or amending the
Loan Documents, and (i) Agent’s and each Lender’s costs and expenses (including attorneys’, accountants’, consultants’, and other advisors’ fees and expenses) incurred in terminating, enforcing (including
attorneys’, accountants’, consultants’, and other advisors’ fees and expenses incurred in connection with a “workout,” a “restructuring,” or an Insolvency Proceeding concerning Borrower or any of its
Subsidiaries or any Guarantor or in exercising rights or remedies under the Loan Documents), or defending the Loan Documents, irrespective of whether suit is brought, or in taking any Remedial Action concerning the Collateral. All such amounts
representing a mere pass-through by a member of the Lender Group of out-of-pocket costs and expenses set by a third-party shall be deemed to be reasonable for purposes of this Agreement and other Loan Documents. 

2.15 Amendment to Definition of LIBOR Rate Margin. Section 1.1 of the Loan Agreement is amended by
deleting the existing definition of the term “LIBOR Rate Margin” and replacing it with the following amended and restated version thereof: 
 “LIBOR Rate Margin” means three and one-half percent (3.50%). 

  
 - 5 -

 2.16 Amendment to Definition of Loan Documents.
Section 1.1 of the Loan Agreement is amended by deleting from the existing definition of the term “Loan Documents” the words “the Bank Product Agreements,”. 

2.17 Addition of Definition of OFAC. Section 1.1 of the Loan Agreement is amended by adding in
appropriate alphabetical order the following new definition of the term “OFAC”: 

“OFAC” means The Office of Foreign Assets Control of the U.S. Department of the Treasury. 

2.18 Addition of Definitions of Second Amendment, Second Amendment Closing Date and Second Amendment Closing Fee.
Section 1.1 of the Loan Agreement is amended by adding in appropriate alphabetical order the following new definitions of the terms “Second Amendment,” “Second Amendment Closing Date,” and “Second Amendment
Closing Fee”: 
 “Second Amendment” means the Second Amendment to Loan and Security
Agreement, dated as of June 20, 2011, by and among Lenders, Agent and Borrower. 
 “Second Amendment
Closing Date” means June 20, 2011. 
 “Second Amendment Closing Fee” has the
meaning given to such term in the Fee Letter. 
 2.19 Amendment to Definition of WFF.
Section 1.1 of the Loan Agreement is amended by deleting the existing definition of the term “WFF” and replacing it with the following amended and restated version thereof: 

“WFF” means Wells Fargo Capital Finance, LLC, a Delaware limited liability company formerly known as
Wells Fargo Foothill, LLC. 
 2.20 Amendment to Rules of Construction. Section 1.4 of the Loan
Agreement is amended by deleting the third to the last sentence thereof and replacing it with the following two sentences: 
 The
words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties. Any reference herein or in any other Loan Document to the
satisfaction, repayment, or payment in full of the Obligations shall mean the repayment in full in cash or immediately available funds (or, in the case of obligations with respect to Bank Products (other than Hedge Obligations), providing Bank
Product Collateralization) of all of the Obligations (including the payment of any Lender Group Expenses that have accrued irrespective of whether demand has been made therefor and the payment of any termination amount then applicable (or which

  
 - 6 -

 
would or could become applicable as a result of the repayment of the other Obligations) under Hedge Agreements provided by Hedge Providers) other than (i) unasserted contingent
indemnification Obligations, (ii) any Bank Product Obligations (other than Hedge Obligations) that, at such time, are allowed by the applicable Bank Product Provider to remain outstanding without being required to be repaid or cash
collateralized, and (iii) any Hedge Obligations that, at such time, are allowed by the applicable Hedge Provider to remain outstanding without being required to be repaid. 

2.21 Amendment to Apportionment and Application of Payments. Section 2.3(b) of the Loan Agreement is
amended by deleting the existing text of Sections 2.3(b)(i)(K), (L), (M) and (N), and replacing them with the following amended and restated versions thereof: 

(K) eleventh, so long as no Event of Default has occurred and is continuing, and at Agent’s election (which
election Agent agrees will not be made if an Overadvance would be created thereby), ratably, to the Bank Product Providers based upon amounts then certified by the applicable Bank Product Provider to Agent (in form and substance satisfactory to
Agent) to be due and payable to such Bank Product Providers on account of Bank Product Obligations, 
 (L)
twelfth, so long as no Event of Default has occurred and is continuing, to pay the principal of all Advances, until paid in full, 
 (M) thirteenth, if an Event of Default has occurred and is continuing, ratably (i) to pay the principal of all Advances until paid in full, and (ii) ratably, to the Bank Product
Providers, in an aggregate amount up to the Bank Product Reserve established prior to the occurrence of, and not in contemplation of, the subject Event of Default, based upon amounts then certified by the applicable Bank Product Provider to Agent
(in form and substance satisfactory to Agent) to be due and payable to such Bank Product Providers on account of Bank Product Obligations, 
 (N) fourteenth, if an Event of Default has occurred and is continuing, to pay any other Obligations (including being paid, ratably, to the Bank Product Providers on account of all amounts then due
and payable in respect of Bank Product Obligations, with any balance to be paid to Agent, to be held by Agent, for the ratable benefit of the Bank Product Providers, as cash collateral), and 

2.22 Amendment to Payment of Interest and Fees. Section 2.5 of the Loan Agreement is amended by
deleting the second sentence of Section 2.5(c) and replacing it with the following amended and restated version thereof: 
 Borrower hereby authorizes Agent, from time to time without prior notice to Borrower, to charge all interest and fees (when due and payable), all Lender Group Expenses (as and when incurred), the fees and
costs provided for in Section 2.10 (as and when accrued or incurred), and all other payments as and when due and 

  
 - 7 -

 
payable under any Loan Document or any Bank Product Agreement (including any amounts due and payable to the Bank Product Providers in respect of Bank Products up to the Bank Product Reserve
Amount) to Borrower’s Loan Account, which amounts thereafter constitute Advances hereunder and shall accrue interest at the rate then applicable to Advances hereunder. 

2.23 Amendment to Unused Line Fee. Section 2.10 of the Loan Agreement is amended by deleting the
existing text of Section 2.10(a) and replacing it with the following amended and restated version thereof: 
 (a) Unused Line Fee. On the first day of each month, Borrower shall pay an unused line fee equal to (i) the amount by which (A) the Maximum Revolver Amount then in effect exceeds
(B) the average Daily Balance of Advances that were outstanding during the immediately preceding month, or portion thereof during which this Agreement is in effect, multiplied by (ii) (A) for each payment date occurring
on or before September 1, 2011, three-tenths of one percent (0.30%), and (B) for each payment date occurring after September 1, 2011, (I) if the average Daily Balance of Advances that were outstanding during such month was equal
to or less than sixty percent (60%) of the average Maximum Revolver Amount in effect during such month, then three-quarters of one percent (0.75%) per annum, (II) if the average Daily Balance of Advances that were outstanding during such
month was greater than sixty percent (60%), but equal to or less than eighty percent (80%), of the average Maximum Revolver Amount in effect during such month, then one-half of one percent (0.50%) per annum, and (III) if the average Daily
Balance of Advances that were outstanding during such month was greater than eighty percent (80%) of the average Maximum Revolver Amount in effect during such month, then zero (0). 

2.24 Amendment to Audit, Appraisal and Valuation Charges. Section 2.10 of the Loan Agreement is amended
by deleting the existing text of Section 2.10(c) and replacing it with the following amended and restated version thereof: 
 (c) Audit, Appraisal, and Valuation Charges. For the separate account of Agent, Borrower shall pay to Agent audit, appraisal, and valuation fees and charges as follows (i) a fee of $1,200 per
day, per auditor, plus out-of-pocket expenses for each financial or collateral audit of Borrower performed by personnel employed by Agent, (ii) a fee of $1,000 per day, per applicable individual, plus out of pocket expenses for the
establishment of electronic collateral reporting systems, if requested by Agent, (iii) a fee of $1,500 per day per appraiser, plus out-of-pocket expenses, for each appraisal of the Collateral, or any portion thereof, performed by personnel
employed by Agent, and (iv) the actual charges paid or incurred by Agent if it elects to employ the services of one or more third Persons to perform financial or collateral audits of Borrower or its Subsidiaries, to establish electronic
collateral reporting systems, to appraise the Collateral or any portion thereof, or to assess Borrower’s or its Subsidiaries’ procedures or business valuation; provided that so long as no Event of Default has occurred and is
continuing, Borrower will not be charged for more than three (3) financial or collateral audits in any twelve-month period. 

  
 - 8 -

 2.25 Addition of New Condition Subsequent. Section 3.2 of
the Loan Agreement is amended by adding the following new Section 3.2(d) after the existing text thereof: 
 (d) Within one hundred eighty (180) days after the Second Amendment Closing Date, both Borrower and HTGC shall have transferred all of their respective treasury management accounts to Wells Fargo.

 2.26 Amendment to Maturity Date. Section 3.4 of the Loan Agreement is amended by deleting
the existing text thereof and replacing it with the following amended and restated version thereof: 
 3.4
Term. This Agreement shall continue in full force and effect for a term commencing on the Closing Date and ending on the third anniversary of the Second Amendment Closing Date (the “Maturity Date”). The foregoing
notwithstanding, the Lender Group, upon the election of the Required Lenders, shall have the right to terminate its obligations under this Agreement immediately and without notice upon the occurrence and during the continuation of an Event of
Default. 
 2.27 Amendment to Effect of Termination. Section 3.5 of the Loan Agreement is
amended by deleting the first sentence thereof and replacing it with the following amended and restated version thereof: 
 On
the Maturity Date or earlier termination of this Agreement in accordance with its terms, all of the Obligations immediately shall become due and payable without notice or demand and Borrower shall be required to repay all of the Obligations in full.

 2.28 Amendment to Early Termination by Borrower. Section 3.6 of the Loan Agreement is
amended by deleting the existing text thereof and replacing it with the following amended and restated version thereof: 
 3.6 Early Termination by Borrower. Borrower has the option, at any time upon ninety (90) days prior written notice to Agent, to terminate this Agreement by repaying to Agent all of the
Obligations in full. If Borrower has sent a notice of termination pursuant to the provisions of this Section 3.6, then the Commitments shall terminate and Borrower shall be obligated to repay the Obligations in full, on the date set
forth as the date of termination of this Agreement in such notice. In the event of the termination of this Agreement and repayment of the Obligations at any time prior to the Maturity Date, for any other reason, including (a) termination upon
the election of the Required Lenders to terminate after the occurrence and during the continuation of an Event of Default, (b) foreclosure by Agent or Lenders and sale of Collateral, (c) sale of the Collateral in any Insolvency Proceeding
of Borrower, or (d) restructure, 

  
 - 9 -

 
reorganization, or compromise of the Obligations by the confirmation of a plan of reorganization or any other plan of compromise, restructure, or arrangement in any Insolvency Proceeding of
Borrower, then, in view of the impracticability and extreme difficulty of ascertaining the actual amount of damages to the Lender Group or profits lost by the Lender Group as a result of such early termination, and by mutual agreement of the parties
as to a reasonable estimation and calculation of the lost profits or damages of the Lender Group, Borrower shall pay to Agent, in cash, for the ratable benefit of Lenders, the Applicable Prepayment Premium, if any, determined as of such date. For
purposes of this Agreement, “Applicable Prepayment Premium” means, as of any date of determination, an amount equal to (a) during the period starting on the Second Amendment Closing Date and ending on the day immediately
preceding the first anniversary of the Second Amendment Closing Date, three percent (3.00%) times the Maximum Revolver Amount on such date, (b) during the period starting on the first anniversary of the Second Amendment Closing Date
and ending on the day immediately preceding the second anniversary of the Second Amendment Closing Date, two percent (2.00%) times the Maximum Revolver Amount on such date, (c) during the period starting on the second anniversary of
the Second Amendment Closing Date and ending on the day immediately preceding the same date in the sixth month after the second anniversary of the Second Amendment Closing Date, one percent (1.00%) times the Maximum Revolver Amount on
such date, and (d) thereafter, zero dollars ($0.00). 
 2.29 Amendment to Covenant Regarding Minimum
Tangible Net Worth of HTGC. Section 7.16 of the Loan Agreement is amended by deleting the existing text of Section 7.16(c) and replacing it with the following amended and restated version thereof: 

(c) Minimum Tangible Net Worth of HTGC. Permit HTGC, on a consolidated basis with its Subsidiaries, to fail to
maintain as of the end of each of its fiscal quarters a sum of (i) Tangible Net Worth, plus (ii) Subordinated Debt, that is greater than or equal to the sum of (A) $314,000,000, plus (B) ninety percent (90%) of
the cumulative amount of equity raised by HTGC from and after March 31, 2011. 
 2.30 Amendment to
Lenders’ Rights and Remedies. Section 9.1 of the Loan Agreement is amended by deleting the existing text of Section 9.1(a) and replacing it with the following amended and restated version thereof: 

(a) Declare all or any portion of the Obligations (other than the Bank Product Obligations), whether evidenced by this
Agreement or by any of the other Loan Documents, immediately due and payable, whereupon the same shall become and be immediately due and payable and Borrower shall be obligated to repay all of such Obligations in full; 

  
 - 10 -

 2.31 Further Amendment to Lenders’ Rights and Remedies.
Section 9.1 of the Loan Agreement is further amended by deleting the existing text of the last paragraph thereof and replacing it with the following amended and restated version thereof: 

The foregoing to the contrary notwithstanding, upon the occurrence of any Event of Default described in Section 8.4 or
Section 8.5, in addition to the remedies set forth above, without any notice to Borrower or any other Person or any act by the Lender Group, the Commitments shall automatically terminate and the Obligations (other than the Bank Product
Obligations), inclusive of all accrued and unpaid interest thereon and all fees and all other amounts owing under this Agreement or under any of the other Loan Documents, shall automatically and immediately become due and payable and Borrower shall
be obligated to repay all of such Obligations in full, without presentment, demand, protest, or notice of any kind, all of which are expressly waived by Borrower. 

2.32 Amendment to Provision Regarding Amendments and Waivers. Section 15.1 of the Loan Agreement is
amended by deleting from the first sentence thereof the words “Bank Product Agreements or”. 
 2.33
Amendment to Agency Provisions Regarding Collateral Matters Providers. Section 16.12 of the Loan Agreement is amended by deleting the existing text thereof and replacing it with the following amended and restated version thereof:

 16.12 Collateral Matters. 

(a) The Lenders hereby irrevocably authorize (and by entering into a Bank Product Agreement, each Bank Product Provider
shall be deemed to authorize) Agent to release any Lien on any Collateral (i) upon the termination of the Commitments and payment and satisfaction in full by Borrower of all of the Obligations, (ii) constituting property being sold or
disposed of if a release is required or desirable in connection therewith and if such sale or disposition is a Permitted Disposition or Borrower certifies to Agent that the sale or disposition is permitted under Section 7.4 (and Agent
may rely conclusively on any such certificate, without further inquiry), (iii) constituting property in which Borrower owned no interest at the time Agent’s Lien was granted nor at any time thereafter, or (iv) constituting property
leased to Borrower under a lease that has expired or is terminated in a transaction permitted under this Agreement. Borrower and the Lenders hereby irrevocably authorize (and by entering into a Bank Product Agreement, each Bank Product Provider
shall be deemed to authorize) Agent, based upon the instruction of the Required Lenders, to (a) consent to, credit bid or purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral at any sale
thereof conducted under the provisions of the Bankruptcy Code, including under Section 363 of the Bankruptcy Code, (b) credit bid or purchase (either directly or through one or more acquisition vehicles) all or any portion of the
Collateral at any sale or other disposition thereof conducted under the provisions of the Code, including pursuant to Sections 9-610 or 9-620 of the Code, or (c) credit bid or purchase (either directly or through one or more acquisition
vehicles) all or any portion of the Collateral at any other sale or foreclosure conducted by Agent (whether by judicial action or otherwise) in accordance with applicable law. In connection with any such credit bid or purchase, the Obligations owed
to the Lenders and the Bank Product Providers 

  
 - 11 -

 
shall be entitled to be, and shall be, credit bid on a ratable basis (with Obligations with respect to contingent or unliquidated claims being estimated for such purpose if the fixing or
liquidation thereof would not unduly delay the ability of Agent to credit bid or purchase at such sale or other disposition of the Collateral and, if such claims cannot be estimated without unduly delaying the ability of Agent to credit bid, then
such claims shall be disregarded, not credit bid, and not entitled to any interest in the asset or assets purchased by means of such credit bid) and the Lenders and the Bank Product Providers whose Obligations are credit bid shall be entitled to
receive interests (ratably based upon the proportion of their Obligations credit bid in relation to the aggregate amount of Obligations so credit bid) in the asset or assets so purchased (or in the Stock of the acquisition vehicle or vehicles that
are used to consummate such purchase). Except as provided above, Agent will not execute and deliver a release of any Lien on any Collateral without the prior written authorization of (y) if the release is of all or substantially all of the
Collateral, all of the Lenders (without requiring the authorization of the Bank Product Providers), or (z) otherwise, the Required Lenders (without requiring the authorization of the Bank Product Providers). Upon request by Agent or Borrower at
any time, the Lenders will (and if so requested, the Bank Product Providers will) confirm in writing Agent’s authority to release any such Liens on particular types or items of Collateral pursuant to this Section 16.12;
provided, however, that (1) Agent shall not be required to execute any document necessary to evidence such release on terms that, in Agent’s opinion, would expose Agent to liability or create any obligation or entail any
consequence other than the release of such Lien without recourse, representation, or warranty, and (2) such release shall not in any manner discharge, affect, or impair the Obligations or any Liens (other than those expressly being released)
upon (or obligations of Borrower in respect of) all interests retained by Borrower, including, the proceeds of any sale, all of which shall continue to constitute part of the Collateral. The Lenders further hereby irrevocably authorize (and by
entering into a Bank Product Agreement, each Bank Product Provider shall be deemed to authorize) Agent, at its option and in its sole discretion, to subordinate any Lien granted to or held by Agent under any Loan Document to the holder of any
Permitted Lien on such property if such Permitted Lien secures Permitted Purchase Money Indebtedness. 
 (b)
Agent shall have no obligation whatsoever to any of the Lenders (or the Bank Product Providers) to assure that the Collateral exists or is owned by Borrower or is cared for, protected, or insured or has been encumbered, or that Agent’s Liens
have been properly or sufficiently or lawfully created, perfected, protected, or enforced or are entitled to any particular priority, or that any particular items of Collateral meet the eligibility criteria applicable in respect thereof or whether
to impose, maintain, reduce, or eliminate any particular reserve hereunder or whether the amount of any such reserve is appropriate or not, or to exercise at all or in any particular manner or under any duty of care, disclosure or fidelity, or to
continue exercising, any of the rights, authorities and powers granted or available to Agent pursuant to any of the Loan Documents, it being understood and agreed that in respect of the Collateral, or any act, omission, or event related thereto,
subject to the terms and conditions contained herein, Agent may act in any 

  
 - 12 -

 
manner it may deem appropriate, in its sole discretion given Agent’s own interest in the Collateral in its capacity as one of the Lenders and that Agent shall have no other duty or liability
whatsoever to any Lender (or Bank Product Provider) as to any of the foregoing, except as otherwise provided herein. 
 2.34 Amendment to Agency Provisions Regarding Bank Product Providers. Section 16.19 of the Loan Agreement is amended by deleting the existing text thereof and replacing it with the
following amended and restated version thereof: 
 16.19 Bank Product Providers. Each Bank Product
Provider shall be deemed a third party beneficiary hereof and of the provisions of the other Loan Documents for purposes of any reference in a Loan Document to the parties for whom Agent is acting. Agent hereby agrees to act as agent for such Bank
Product Providers and, by virtue of entering into a Bank Product Agreement, the applicable Bank Product Provider shall be automatically deemed to have appointed Agent as its agent and to have accepted the benefits of the Loan Documents, and to have
provided Agent with the same authorizations, representations, acknowledgments and consents made by each Lender under the preceding Sections 16.1 through 16.18; it being understood and agreed that the rights and benefits of each Bank
Product Provider under the Loan Documents consist exclusively of such Bank Product Provider’s being a beneficiary of the Liens and security interests (and, if applicable, guarantees) granted to Agent and the right to share in payments and
collections out of the Collateral as more fully set forth herein. In addition, each Bank Product Provider, by virtue of entering into a Bank Product Agreement, shall be automatically deemed to have agreed that Agent shall have the right, but shall
have no obligation, to establish, maintain, relax, or release reserves in respect of the Bank Product Obligations and that if reserves are established there is no obligation on the part of Agent to determine or insure whether the amount of any such
reserve is appropriate or not. In connection with any such distribution of payments or proceeds of Collateral, Agent shall be entitled to assume no amounts are due or owing to any Bank Product Provider unless such Bank Product Provider has provided
a written certification (setting forth a reasonably detailed calculation) to Agent as to the amounts that are due and owing to it and such written certification is received by Agent a reasonable period of time prior to the making of such
distribution. Agent shall have no obligation to calculate the amount due and payable with respect to any Bank Products, but may rely upon the written certification of the amount due and payable from the relevant Bank Product Provider. In the absence
of an updated certification, Agent shall be entitled to assume that the amount due and payable to the relevant Bank Product Provider is the amount last certified to Agent by such Bank Product Provider as being due and payable (less any distributions
made to such Bank Product Provider on account thereof). Borrower may obtain Bank Products from any Bank Product Provider, although Borrower is not required to do so. Borrower acknowledges and agrees that no Bank Product Provider has committed to
provide any Bank Products and that the providing of Bank Products by any Bank Product Provider is in the sole and absolute discretion of such Bank Product Provider. Notwithstanding anything to the contrary in this Agreement or any other Loan
Document, no provider or 

  
 - 13 -

 
holder of any Bank Product shall have any voting or approval rights hereunder (or be deemed a Lender) solely by virtue of its status as the provider or holder of such agreements or products or
the Obligations owing thereunder, nor shall the consent of any such provider or holder be required (other than in their capacities as Lenders, to the extent applicable) for any matter hereunder or under any of the other Loan Documents (except the
Bank Product Agreements of the applicable Bank Product Provider), including as to any matter relating to the Collateral or the release of Collateral or Guarantors. 

2.35 Amendment to Provisions Regarding Patriot Act. Section 17.9 of the Loan Agreement is amended by
adding after the existing text thereof the following additional sentence: 
 In addition, if Agent is required by law or
regulation or internal policies to do so, it shall have the right to periodically conduct (a) Patriot Act searches, OFAC/PEP searches, and customary individual background checks for HTGC or Borrower and (b) OFAC/PEP searches and customary
individual background checks for the senior management and key principals of HTGC or Borrower, and Borrower agrees to cooperate in respect of the conduct of such searches and further agrees that the reasonable costs and charges for such searches
shall constitute Lender Expenses hereunder and be for the account of Borrower. 
 2.36 Amendment to
Integration Provision. Section 17.10 of the Loan Agreement is amended by adding after the existing text thereof the following additional sentence: 
 The foregoing to the contrary notwithstanding, all Bank Product Agreements, if any, are independent agreements governed by the written provisions of such Bank Product Agreements, which will remain in full
force and effect, unaffected by any repayment, prepayments, acceleration, reduction, increase, or change in the terms of any credit extended hereunder, except as otherwise expressly provided in such Bank Product Agreement. 

2.37 Revised Commitments as of the Second Amendment Closing Date. Exhibit C-1 to the Loan Agreement is
amended by deleting the existing version thereof and replacing it with the revised and current version attached as Exhibit A to this Second Amendment. 
 3. Conditions Precedent. Notwithstanding any other provision of this Second Amendment, this Second Amendment shall be of no force or effect, and Lenders and Agent shall not have any obligations
hereunder, unless and until each of the following conditions have been satisfied: 
 3.1 Receipt of Executed
Second Amendment. Agent shall have received this Second Amendment, duly executed by Borrower, each Lender, and Agent; 
 3.2 Receipt of Executed Amended and Restated Fee Letter. Agent shall have received the Fee Letter, duly executed by Borrower and Agent; 

  
 - 14 -

 3.3 Payment of Second Amendment Closing Fee. Agent shall have
received from Borrower payment of the Second Amendment Closing Fee; and 
 3.4 Secretary’s
Certificate. Agent shall have received a certificate from the Secretary of Borrower attesting to (a) the resolutions of Borrower’s Board of Directors (i) authorizing Borrower’s execution, delivery, and performance of this
Second Amendment, the Fee Letter, and all other Loan Documents executed in connection therewith to which Borrower is a party, and (ii) authorizing specific officers of Borrower to execute the same, and (b) the incumbency and signatures of
such specific officers of Borrower. 
 3.5 Closing Certificate. Agent shall have received a certificate
from the chief financial officer and chief executive officer of Borrower, certifying as to (a) the truth and accuracy of the representations and warranties of Borrower contained in Section 5 of the Loan Agreement as amended by this
Second Amendment, (b) the absence of any Defaults or Events of Default, and (c) that after giving effect to the incurrence of Indebtedness under the Loan Agreement and the other transactions contemplated by the Loan Agreement as amended by
this Second Amendment, Borrower is Solvent; 
 3.6 Opinion of Borrower’s Counsel. Agent shall have
received an opinion or opinions of Borrower’s counsel in form and substance satisfactory to Agent. 
 4. Representations
and Warranties re Loan Agreement. Borrower hereby represents and warrants that the representations and warranties contained in the Loan Agreement were true and correct in all material respects when made and, except to the extent that (a) a
particular representation or warranty by its terms expressly applies only to an earlier date, or (b) Borrower has previously advised Agent in writing as contemplated under the Loan Agreement, are true and correct in all material respects as of
the date hereof. Borrower hereby further represents and warrants that no event has occurred and is continuing, or would result from the transactions contemplated under this Second Amendment, that constitutes or would constitute a Default or an Event
of Default. 
 5. Miscellaneous. 
 5.1 Headings. The various headings of this Second Amendment are inserted for convenience of reference only and shall not affect the meaning or interpretation of this Second Amendment or any
provisions hereof. 
 5.2 Counterparts. This Second Amendment may be executed by the parties hereto in
several counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument. Delivery of an executed counterpart of a signature page to this Second Amendment by either
(i) facsimile transmission or (ii) electronic transmission in either Tagged Image Format Files (TIFF) or Portable Document Format (PDF), shall be effective as delivery of a manually executed counterpart thereof. 

5.3 Interpretation. No provision of this Second Amendment shall be construed against or interpreted to the
disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party’s having or being deemed to have structured, drafted or dictated such provision. 

  
 - 15 -

 5.4 Complete Agreement. This Second Amendment constitutes the
complete agreement between the parties with respect to the subject matter hereof, and supersedes any prior written or oral agreements, writings, communications or understandings of the parties with respect thereto. 

5.5 GOVERNING LAW. THIS SECOND AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH,
THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND PERFORMED IN SUCH STATE, WITHOUT REGARD TO THE PRINCIPLES THEREOF REGARDING CONFLICT OF LAWS. 

5.6 Effect. Upon the effectiveness of this Second Amendment, each reference in the Loan Agreement to “this
Agreement,” “hereunder,” “hereof” or words of like import shall mean and be a reference to the Loan Agreement as amended hereby and each reference in the other Loan Documents to the Loan Agreement, “thereunder,”
“thereof,” or words of like import shall mean and be a reference to the Loan Agreement as amended hereby. 
 5.7 Conflict of Terms. In the event of any inconsistency between the provisions of this Second Amendment and any provision of the Loan Agreement, the terms and provisions of this Second Amendment
shall govern and control. 
 5.8 No Novation or Waiver. Except as specifically set forth in this Second
Amendment, the execution, delivery and effectiveness of this Second Amendment shall not (a) limit, impair, constitute a waiver by, or otherwise affect any right, power or remedy of, Agent or Lenders under the Loan Agreement or any other Loan
Document, (b) constitute a waiver of any provision in the Loan Agreement or in any of the other Loan Documents or of any Default or Event of Default that may have occurred and be continuing, or (c) alter, modify, amend or in any way affect
any of the terms, conditions, obligations, covenants or agreements contained in the Loan Agreement or in any of the other Loan Documents, all of which are ratified and affirmed in all respects and shall continue in full force and effect. 

[SIGNATURE PAGE FOLLOWS] 

  
 - 16 -

 IN WITNESS WHEREOF, the parties hereto have executed this Second Amendment to Loan and
Security Agreement as of the day and year first above written. 
  

			
	 HERCULES FUNDING II LLC,
 a Delaware limited liability company, as Borrower

		
	By:	 	/s/ Scott Harvey
	Name:	 	Scott Harvey
	Title:	 	Chief Legal Officer
	
	 WELLS FARGO CAPITAL FINANCE, LLC,
 formerly known as Wells Fargo Foothill, LLC,
 a Delaware limited liability company,

as Agent and a Lender

		
	 By:
	 	/s/ Aharon Tarnavsky
	Name:	 	 Aharon Tarnavsky

	Title:	 	 Vice President

  
 - 17 -

 EXHIBIT A TO SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT 

Exhibit C-1 
 To 
 Loan and Security Agreement 

Commitments 
 (as of Second Amendment Closing Date) 
  

			
	 Lender
	  	 Commitment

	 Wells Fargo Foothill, LLC.
	  	$75,000,000
	 All Lenders
	  	$75,000,000

  
 - 18 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]